SRx is a distressed penny-stock turnaround attempting to reinvent itself from bankrupt healthcare remnants and premium pet food into an AI-driven crypto treasury platform, but dilution and balance-sheet risk dominate the upside story.
Overview
SRx Health Solutions is a distressed micro-cap undergoing a radical transformation. After its Canadian specialty healthcare operations entered CCAA bankruptcy and were discontinued, the company’s continuing business is Halo, a premium pet food brand sold mainly through Amazon, Chewy, pet specialty retailers, and select international channels. SRx is now attempting another pivot via a proposed $55 million all-stock acquisition of EMJX, an AI-enabled digital-asset treasury and risk-management platform. The upside is speculative and catalyst-driven, but the investment profile is dominated by dilution, debt, losses, and going-concern risk.